US Edition
Published • loading... • Updated
Tylenol in pregnancy not linked with autism, Danish study finds
The findings held after researchers adjusted for dose and trimester, and they matched a 2024 Swedish study of more than 1.5 million children.
- On Monday, a large Danish study published in JAMA Pediatrics found no evidence linking Tylenol use during pregnancy to Autism in children.
- A 2024 Swedish study reported no association between Tylenol and Autism, while a 2025 review of 46 studies by American researchers suggested a possible link between prenatal acetaminophen exposure and neurodevelopmental disorders.
- Researchers analyzed data from more than 1.5 million children born between 1997 and 2022, including 31,098 exposed to Tylenol in the womb; Autism was diagnosed in 1.8% of exposed children versus 3% of unexposed.
- President Donald Trump and Health Secretary Robert Kennedy previously urged pregnant women to limit Tylenol use, but national medical groups later decried such warnings as not evidence-based.
- The FDA remains silent on its planned label change for Tylenol, while Kenvue Inc. warns that avoiding the drug could lead mothers to use less safe pain relief alternatives.
Insights by Ground AI
19 Articles
19 Articles
A broad study conducted in Denmark with more than 1.5 million children concluded that the use of paracetamol — commercially known as Tylenol — during pregnancy is not associated with increased risk of autism in children. The results published in the JAMA Pediatrics scientific magazine this afternoon strengthen recent evidence that avoids the hypotheses of causal relationship between medicines and neurodevelopment disorders.
·Brazil
Read Full Article
Coverage Details
Total News Sources19
Leaning Left1Leaning Right5Center9Last UpdatedBias Distribution60% Center
Bias Distribution
- 60% of the sources are Center
60% Center
C 60%
R 33%
Factuality
To view factuality data please Upgrade to Premium
